Adscientis

Aurora Fine Chemicals is a privately held company that was founded in 1990. As a chemicals R&D supplier we offer chemicals for R&D, drug discovery service, compound libraries and custom synthesis. We have one of the largest collections of 18.1 mln. chemicals available in stock and our docking software delivers hits/leads of very high quality in short time.

Our staff consists of highly qualified individuals with Bsc, Msc and Ph.D. degrees in chemistry, as well as excellent laboratory technicians. In our Molecular Modeling Group are professionals specializing in computational drug design. They possess many years experience of working in the chemistry of heterocycles, carbohydrates, nucleosides and elemental organic compounds. Aurora has significant expertise in synthesis of all types R&D chemicals for drug discovery like small molecules, natural products and peptides. Parallel synthesis with well-designed, targeted and fragment-based libraries is the favored approach to lead optimization. Rational design is the strategy for projects driven by structural biology, such as enzyme inhibitors or protein interactions.

We own a large library of 18.1 million stocked compounds for R&D. Our substances are used in many research labs all over the world. We offer structures for biochemical and chemical research. Our products are applied in pharmaceutical development, diagnosis, and in chemical production.

Several laboratories for synthesis with modern equipment such as reactors, autoclaves, thermostats and hydrogenation equipment are available.

Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorption analysis and crystallographical methods.

The main advantage of Aurora's own software is the quality of the underlying physical models. Aurora's software derives molecular properties from first principles based on direct models using advanced quantum mechanical analysis of molecular interactions and thermodynamics.

We support life science organisations by solving their research and development problems.

With extensive background in chemical and pharmaceutical industries our team provides consultancy services covering project management, outsourcing, manufacturing and training.

By going beyond the conventional consultancy model and tackling the chemistry challenges directly we divert compound manufacture and supply risks from our clients. Our undertaking to produce the molecules you need frees your time to focus on other discovery and development objectives.

Our individually tailored solutions address key R&D needs including:

Project management;
Filling the resource and skills gap by providing project management

Synthesis and manufacturing;
Synthesising non-commercial compound and fine chemicals
Helping with developing and producing drug candidates to cGMP

Material supply;
Finding hard-to-find commercial fine chemicals and active drugs

Technology solutions;
Identifying enabling technologies that facilitate drug development

Training;
If you wish to use your scientific, technical, or management expertise to work as independent consultants we provide you with the necessary training to set up your business.
Our course provides step-by-step training for people who have extensive scientific or technical background and have worked in the industry, public sector or academia before and now wish to work as independent consultants.
The course is accredited and is approved by the Royal Society of Chemistry for Continuing Professional Development (CPD).

FeyeCon is all about innovation and game-changing, clean technology. We are a true process and product development company and global leader in CO₂ technology. Using our technology we strive to achieve a clean and sustainable planet. Don’t mistake us for just a research company. What sets us apart is the combination of R&D activities and a market driven approach. This is what makes us successful.

FeyeCon was founded by our CEO Dr. Geert Woerlee, who developed influential carbon dioxide technology during his time at the Delft University of Technology in the Netherlands. Dr. Woerlee created FeyeCon with CO₂ technology as its foundation and hired the first employees in 2001. Since then FeyeCon has grown in terms of employees, intellectual property and experience in many different industries. Currently we have 50 employees in the Netherlands (HQ) and 150 worldwide. With ten successful joint ventures and branch offices in Asia and the US we continue to grow rapidly. We are very proud to say we partner with companies such as Nike, Ikea and many others. Because our CO₂ technology is so diverse and multi-applicable, we continue to develop new applications and products, striving to have a positive impact on as many industries as possible.

We believe that virtually all products and production processes can benefit from our CO₂ technology. FeyeCon offers tailor-made process design and equipment at bench, pilot and production scales. Whether it’s a completely new concept or optimizing existing technology, FeyeCon delivers customized solutions. CO₂ equipment is available on a contract basis, and we offer demonstrations and feasibility testing on our pilot scale facilities. We combine customer input and interdisciplinary knowledge to realize innovative and successful concept designs.

Separex, leader in the field of supercritical fluids, stands out from its competitors by the way we work. Indeed, our company is able to provide services which accomodate the way our clients think, from the original idea to the construction of the industrial scale unit.

It all starts with our R&D team who, if need be, do feasibility tests or optimisation at our workshop and who in collaboration with our client define the tasks.
Then our design team develops sustainable solutions in terms of equipment.
Finally, our manufacturing workshop gets on with the task to finalizing the installation.

Our responsiveness to the client's needs and our readiness to design solutions to challenging tasks make Separex a major player in field of supercritical fluids.

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology